CVE-2024-23620
CVE-2024-23620 is a high-severity vulnerability in Ibm Merge Efilm Workstation with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-269.
Key facts
- Severity: High (CVSS 3.x base score 8.8)
- CVSS v2: 6.8
- EPSS exploit prediction: 0% (6th percentile)
- Actively exploited: Not listed in CISA KEV
- EU (EUVD) id: EUVD-2024-21114
- Weakness: CWE-269
- Affected product: Ibm Merge Efilm Workstation
- Published:
- Last modified:
Description
An improper privilege management vulnerability exists in IBM Merge Healthcare eFilm Workstation. A local, authenticated attacker can exploit this vulnerability to escalate privileges to SYSTEM.
Frequently asked questions
- What is CVE-2024-23620?
- An improper privilege management vulnerability exists in IBM Merge Healthcare eFilm Workstation. A local, authenticated attacker can exploit this vulnerability to escalate privileges to SYSTEM.
- How severe is CVE-2024-23620?
- CVE-2024-23620 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2024-23620 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (6th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2024-23620?
- CVE-2024-23620 affects Ibm Merge Efilm Workstation. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2024-23620?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- Does CVE-2024-23620 have an EU (EUVD) identifier?
- Yes. CVE-2024-23620 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-21114.
- When was CVE-2024-23620 published?
- CVE-2024-23620 was published on 2024-01-26 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:ibm:merge_efilm_workstation:*:*:*:*:*:*:*:*
More vulnerabilities in Ibm Merge Efilm Workstation
- CVE-2024-23622 — Critical (CVSS 10.0): A stack-based buffer overflow exists in IBM Merge Healthcare eFilm Workstation license server. A remote,…
- CVE-2024-23621 — Critical (CVSS 10.0): A buffer overflow exists in IBM Merge Healthcare eFilm Workstation license server. A remote, unauthenticated attacker…
- CVE-2024-23619 — Critical (CVSS 9.8): A hardcoded credential vulnerability exists in IBM Merge Healthcare eFilm Workstation. A remote, unauthenticated…
All CVEs affecting Ibm Merge Efilm Workstation →
Other CWE-269 (Improper Privilege Management) vulnerabilities
- CVE-2026-31852 — Critical (CVSS 10.0): Jellyfin is an open-source media system. The code-quality.yml GitHub Actions workflow in jellyfin/jellyfin-ios is…
- CVE-2025-20282 — Critical (CVSS 10.0): A vulnerability in an internal API of Cisco ISE and Cisco ISE-PIC could allow an unauthenticated, remote attacker to…
- CVE-2025-0505 — Critical (CVSS 10.0): On Arista CloudVision systems (virtual or physical on-premise deployments), Zero Touch Provisioning can be used to gain…
- CVE-2023-48418 — Critical (CVSS 10.0): In checkDebuggingDisallowed of DeviceVersionFragment.java, there is a possible way to access adb before SUW…
- CVE-2023-48419 — Critical (CVSS 10.0): An attacker in the wifi vicinity of a target Google Home can spy on the victim, resulting in Elevation of Privilege
- CVE-2023-31273 — Critical (CVSS 10.0): Protection mechanism failure in some Intel DCM software before version 5.2 may allow an unauthenticated user to…
Browse all CWE-269 (Improper Privilege Management) vulnerabilities →